These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 15799093)
21. Can AIDS drug also prevent HIV infection? AIDS Read; 2004 Jan; 14(1):14. PubMed ID: 14959699 [No Abstract] [Full Text] [Related]
22. Predictors of selection of K65R: tenofovir use and lack of thymidine analogue mutations. Valer L; MartÃn-Carbonero L; de Mendoza C; Corral A; Soriano V AIDS; 2004 Oct; 18(15):2094-6. PubMed ID: 15577635 [TBL] [Abstract][Full Text] [Related]
23. Female-initiated prevention strategies key to tackling HIV. Nelson R Lancet Infect Dis; 2007 Oct; 7(10):637. PubMed ID: 17939181 [No Abstract] [Full Text] [Related]
24. We must not let protestors derail trials of pre-exposure prophylaxis for HIV. Lange JM PLoS Med; 2005 Sep; 2(9):e248. PubMed ID: 16008501 [TBL] [Abstract][Full Text] [Related]
25. The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong? Singh JA; Mills EJ PLoS Med; 2005 Sep; 2(9):e234. PubMed ID: 16008507 [TBL] [Abstract][Full Text] [Related]
26. An open-label pilot study to determine the efficacy of lopinavir/ritonavir and tenofovir DF in the treatment of HIV-infected patients experiencing first virologic failure on a non-nucleoside-based regimen. Pierone G; Mieras J; Bulgin-Coleman D; Kantor C; Shearer J; Fontaine L; Fath M AIDS Patient Care STDS; 2008 Apr; 22(4):263-6. PubMed ID: 18422459 [No Abstract] [Full Text] [Related]
27. Impact of tenofovir versus abacavir on HIV-related endothelial dysfunction. Francisci D; Falcinelli E; Belfiori B; Petito E; Fierro T; Baldelli F; Gresele P AIDS Patient Care STDS; 2011 Oct; 25(10):567-9. PubMed ID: 21851265 [No Abstract] [Full Text] [Related]
28. Tenofovir: a pill to prevent HIV? Bonn D Lancet Infect Dis; 2005 Feb; 5(2):78. PubMed ID: 15702509 [No Abstract] [Full Text] [Related]
29. Promising prevention approaches: tenofovir gel and prophylactic use of antiretroviral medications. Krakower D; Mayer KH Curr HIV/AIDS Rep; 2011 Dec; 8(4):241-8. PubMed ID: 22002729 [TBL] [Abstract][Full Text] [Related]
30. Cambodia: can a drug provide some protection? Cohen J Science; 2003 Sep; 301(5640):1660-1. PubMed ID: 14500956 [No Abstract] [Full Text] [Related]
31. Tenofovir gel--the new HIV prevention 'banker'? Bateman C S Afr Med J; 2007 Jul; 97(7):496, 498. PubMed ID: 17805450 [No Abstract] [Full Text] [Related]
32. Prophylactic tenofovir reduced HIV infection in injectable drug users. Bender BS Ann Intern Med; 2013 Sep; 159(6):JC8. PubMed ID: 24042391 [No Abstract] [Full Text] [Related]
33. [Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV]. Bayonne Kombo ES; Gathse A Med Mal Infect; 2013 Mar; 43(3):134-5. PubMed ID: 23434355 [No Abstract] [Full Text] [Related]
34. FDA approves three generics. AIDS Patient Care STDS; 2009 Apr; 23(4):305. PubMed ID: 19358692 [No Abstract] [Full Text] [Related]
35. Tenacious tenofovir struts its stuff in a virtual ICAAC. Huff B GMHC Treat Issues; 2001 Oct; 15(10):9-11. PubMed ID: 11727571 [No Abstract] [Full Text] [Related]
36. Tenofovir helps prevent HIV in drug users. BMJ; 2013 Jun; 346():f3871. PubMed ID: 23777811 [No Abstract] [Full Text] [Related]
37. Encouraging results for tenofovir. AIDS Patient Care STDS; 2001 May; 15(5):289. PubMed ID: 11530770 [No Abstract] [Full Text] [Related]
38. Tenofovir gel studied. AIDS Patient Care STDS; 2002 Aug; 16(8):401-2. PubMed ID: 12227991 [No Abstract] [Full Text] [Related]
39. FDA notifications. FDA approves generic combination of efavirenz, lamivudine & tenofovir. AIDS Alert; 2009 Nov; 24(11):130. PubMed ID: 19960612 [No Abstract] [Full Text] [Related]
40. HIV transmission may be prevented by intravaginal tenofovir ring. Parks L Future Med Chem; 2012 Dec; 4(18):2239. PubMed ID: 23359902 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]